lisofylline has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shulman, KL; Stadler, WM; Vogelzang, NJ | 1 |
| Atkins, M; Bursten, S; Campbell, E; Doroshow, J; Federighi, D; Fisher, R; Lotze, M; Margolin, K; Mier, J; O'Boyle, K; Rubin, J; Sosman, J; Sparano, J; Weiss, G | 1 |
1 trial(s) available for lisofylline and Cancer of Kidney
| Article | Year |
|---|---|
Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Intravenous; Interleukin-2; Kidney Neoplasms; Melanoma; Middle Aged; Monte Carlo Method; Nausea; Pentoxifylline; Placebos; Prospective Studies; Recombinant Proteins | 1997 |
1 other study(ies) available for lisofylline and Cancer of Kidney
| Article | Year |
|---|---|
High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the University of Chicago experience.
Topics: Adjuvants, Immunologic; Adult; Aged; Carcinoma, Renal Cell; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Pentoxifylline; Remission Induction; Time Factors | 1996 |